Funded projects
Funding decisions
Date of decision
11 June 2024
Requested funding
68
Number of funded projects
Date of decision
17 May 2024
Requested funding
66.6
Number of funded projects
31
Date of decision
17 May 2024
Requested funding
2.7
Number of funded projects
2
Title of the call
Date of decision
08 May 2024
Requested funding
31559
Number of funded projects
54
Date of decision
15 December 2023
Requested funding
676.9
Number of funded projects
3
Date of decision
15 December 2023
Requested funding
221.5
Number of funded projects
3
Date of decision
15 December 2023
Requested funding
1155.8
Number of funded projects
17
Successful projects
All successful projects
New success in the fight against the coronavirus: Hungarian researchers discovered how the Delta variant infects
In a breakthrough in the fight against the coronavirus epidemic, researchers from Pharmacoidea Kft., Szeged have unravelled the secret of the increased infectivity of the dreaded Delta variant, which triggered a new wave of epidemics in 2021. In the project funded by a HUF 350 million grant from the “Investment in the Future” programme and implemented in university-research institute-enterprise cooperation, Dr Tamás Letoha and his research team have successfully elucidated the mechanism of infection. This allows the development of molecularly targeted yet simple strategies to reduce the spread of newer variants and effectively treat the diseases they cause.
25 June 2018
Reading time: 9 minute(s)
Zoltán Nusser, Széchenyi and Bolyai Prize winning neurobiologist and member of the Hungarian Academy of Sciences (HAS) leads the Laboratory of Cellular Neurophysiology at the Institute of Experimental Medicine of HAS. His research was supported by a Momentum (Lendület) grant and an ERC Advanced Grant in the past five years. From 2018, the team continues its work with funding from the Frontline programme of the NRDI Office. His research focuses on the understanding of synaptic communication between nerve cells of the central nervous system.
02 July 2018
Reading time: 7 minute(s)
Biologist Attila Reményi, scientific advisor at the Research Centre for Natural Sciences of the Hungarian Academy of Sciences (RCNS-HAS) was still a student when he conducted research in Bristol. He wrote his PhD thesis at the European Molecular Biology Laboratory in Heidelberg, pursued postdoctoral studies at the University of California - San Francisco, then supported by Wellcome Trust, he returned to Eötvös Loránd University Budapest and later moved to the Research Centre for Natural Sciences of HAS to set up his research group under the Momentum (Lendület) Programme. As from 2018, he continues his work as a winner of the NRDI Office’s Frontline call for proposals.
21 June 2018
Reading time: 8 minute(s)
Recent research indicates that inflammatory processes play an outstanding role in the development of diseases of the nervous system, which are increasingly present in developed societies, however, the underlying mechanisms have not been properly understood. Ádám Dénes, biologist, explained one of their research projects in the field of neuroimmunology, which have been granted funding from the NRDI Office’s Fund as part of the National Competitiveness and Excellence Programme.
Promising projects
All promising projects
20 December 2018
Reading time: 6 minute(s)
Owing to their efficiency and environmental friendly technology, reverse osmosis-based water purification units have become indispensable elements of modern industrial water treatment technologies. The lifespan of these units, however, is not long enough, though it can be successfully extended through continual innovations. Hidrofilt Kft. also contributes to this objective with its project, which has earnt the company a HUF 400 million fund disbursed by the NRDI Office under the call for proposals “Support of business RDI activities” (VÁLLALATI KFI_16).
28 August 2018
Reading time: 9 minute(s)
Modern medicine relies more and more on knowledge acquired in molecular biology and genetics. Therefore, the research into molecular markers revolutionising the diagnosis of diseases has also become extremely timely both for academic basic research and for pharmaceutical research. In order to harmonise the efforts of discovery research and industrial pharmaceutical developments, the Molecular Biomarker Research and Service Centre of Eötvös Loránd University (ELTE Biotechnology HEICC) was established, about the goals and achievements of which, we interviewed Professor Imre Kacskovics, head of Department of Immunology of Eötvös Loránd University (ELTE).
27 August 2018
Reading time: 9 minute(s)
Professor László Gránásy and his team are engaged in modelling the formation of polycrystalline materials, a research they were granted funds for early in 2018 under the “Frontline” – Excellence Programme developed by the NRDI Office. The goal, after having fully understood the crystallisation process, is to use the results in biological systems.
RDI policy opinion
Search for funded projects